ACD/Labs Introduces Andrew Anderson as Vice President of Business Development
News Dec 16, 2015
Anderson joins ACD/Labs from PepsiCo where he was responsible for technology scouting across a variety of research categories. In this role, Anderson spent four years identifying external technologies that deliver value in addressing company goals, and supported the successful in-licensing of technologies by helping to ensure successful implementations. Prior to joining PepsiCo, Anderson spent nearly 10 years in various sales, sales management, and strategic partnership roles at Symyx Technologies, ACD/Labs, as well as an analytical lab manager position at Pfizer.
"ACD/Labs has always been at the forefront of delivering solutions that help R&D organizations become more agile and productive,” said Anderson. “My goal in this new role is to empower our customers by continuing to develop solutions that accelerate scientific research and promote collaboration.”
“This is an exciting time for our company as we grow our informatics business to better address our customers’ evolving needs, and the timing could not be better for Andrew to rejoin the ACD/Labs team,” said Daria Thorp, CEO and President of ACD/Labs. “His expertise, combined with the relationships he has built over the years, will bring a global perspective and strategic approach to driving the growth of our business.”
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.
Towards Personalized Medicine: One Type of Data is Not EnoughNews
To understand the biology of diseased organs researchers use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types. A new computational method jointly analyses different types of molecular data and disentangles the sources of disease variability to guide personalized treatment.READ MORE